Philip Kuehl, PhD

While at the University of Arizona, College of Pharmacy I preformed research in several different areas. One are was in support of the Arizona Cancer Centers skin cancer work. I conducted preformulation studies on the anticancer drug Apomine and helped create a topical formulation to evaluate the efficacy of Apomine in treating skin cancer. Another area of research I worked on while in graduate school was the treatment of lung cancer. My lab developed different inhalation formulations to treat lung cancer.
I am currently working for Lovelace Respiratory Research Institute. At LRRI I work on creating and evaluating inhalation formulations to treat a wide variety of respiratory diseases.
Pharmaceutical Sciences
Pharmaceutics and Pharmacokinetics
Dissertation Title: 
“Preformulation Studies of the Anticancer Drug Imexon”
1. Myrdal, P.B., Karlage, K., Kuehl, P.J., Angersbach, B.S., Merrill, B., Wightman, P., Effect of novel 5-lipoxygenase inhibitors on the incidence of pulmonary adenomas in the A/J murine model when administered via nose-only inhalation. In Press: Carcinogenesis July 2006.
2. Myrdal, P.B., Angersbach, B.S., Karlage, K., Kuehl, P., Chiral separation of lipoxygenase metabolites utilizing HPLC. J. Chrom. A. 1132, (2006), 315-319.
3. Kuehl, P., Carducci, M.D., Myrdal, P.B., 4-Imino-1,3-diaza-bicyclo[3.1.0]hexan-2-one. Acta Cryst. E. (2006), E62, o3688-3690.
4. Kuehl, P., Hoye, W., Myrdal, P.B., Preformulation studies on Imexon. Drug Dev. Ind. Pharm. 32, (2006), 687-697.
5. Kuehl, P., Angersbach, B.S., Stratton, S.P., Myrdal, P.B., Development of an HPLC method for the analysis of Apomine in a topical cream formulation. J. Pharm. Biomed. Anal. 40, (2006), 975-980.
6. Kuehl, P., Carducci, M.D., Myrdal, P.B. An ethanol solvate of beclomethasone dipropionate. Acta Cryst. E. (2003). E59, o1888-o1890.
Alumna or Alumnus: 
Alumni Title/Position/Employer: 
Associate Research Scientist, Lovelace Respiratory Research Institute Albuquerque, NM